logo
Select company
Select metric
-40.41%Return on Equity
VS
Market
22
Sector
56
Industry
71
History
75
$ 5.29Close
$ 3.28 - $ 6.68 52-Week Range
Ticker Information

Ticker

ARDX

Company Name

ARDELYX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARDELYX INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARDX - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 139.53M$ -56.39M-40.41%
3/31/2025$ 145.68M$ -53.76M-36.91%
12/31/2024$ 173.29M$ -39.14M-22.58%
9/30/2024$ 158.3M$ -72.58M-45.85%
6/30/2024$ 146.99M$ -65.14M-44.32%
3/31/2024$ 150.89M$ -65.81M-43.62%
12/31/2023$ 166.82M$ -66.07M-39.6%
9/30/2023$ 191.16M$ -26.57M-13.9%
6/30/2023$ 123.16M$ -56.09M-45.54%
3/31/2023$ 125.42M$ -65.91M-52.55%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARDELYX INC's latest trailing twelve months (TTM) ROE stands at -64.89%.
  • Over the past 5 years, ARDELYX INC's average ROE has been -91.01%.
  • The median ROE for ARDELYX INC during this period was -58.72%
  • ARDELYX INC reached its highest ROE over the past 5 years at -13.9%.
  • The lowest ROE recorded by ARDELYX INC in the same timeframe -254.19%

ARDELYX INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
INVA : INNOVIVA INC 5.41%MDXG : MIMEDX GROUP INC 14.85%MNKD : MANNKIND CORP -RCUS : ARCUS BIOSCIENCES INC -54.28%XERS : XERIS BIOPHARMA HOLDINGS INC -IOVA : IOVANCE BIOTHERAPEUTICS INC -55.82%AUPH : AURINIA PHARMACEUTICALS INC 18.08%TVTX : TRAVERE THERAPEUTICS INC -516.25%ARVN : ARVINAS INC -11.92%IMCR : IMMUNOCORE HOLDINGS PLC -5.23%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ARDELYX INC is calculated as follows: Net Inc. Cmn. [ $ -85.23M ] / Equity [ $ 131.34M ]
(=) ROE [ -64.89% ]

ARDX - Return on Equity, Last 5 years

-254.19%

Minimum

Jun 30, 2022

-13.9%

Maximum

Sep 30, 2023

-91.01%

Average

-58.72%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.52% with a standard deviation of 22.72%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.49%
average1.52%
median6.45%
std22.72%